GB0109263D0 - Method of generating mutant C.elgans exhibiting increased compound uptake - Google Patents

Method of generating mutant C.elgans exhibiting increased compound uptake

Info

Publication number
GB0109263D0
GB0109263D0 GBGB0109263.4A GB0109263A GB0109263D0 GB 0109263 D0 GB0109263 D0 GB 0109263D0 GB 0109263 A GB0109263 A GB 0109263A GB 0109263 D0 GB0109263 D0 GB 0109263D0
Authority
GB
United Kingdom
Prior art keywords
elgans
exhibiting increased
generating mutant
increased compound
compound uptake
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0109263.4A
Other versions
GB2358400B (en
GB2358400A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Devgen NV
Original Assignee
Devgen NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9908677.9A external-priority patent/GB9908677D0/en
Application filed by Devgen NV filed Critical Devgen NV
Priority to GB0109263A priority Critical patent/GB2358400B/en
Publication of GB0109263D0 publication Critical patent/GB0109263D0/en
Publication of GB2358400A publication Critical patent/GB2358400A/en
Application granted granted Critical
Publication of GB2358400B publication Critical patent/GB2358400B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/033Rearing or breeding invertebrates; New breeds of invertebrates
    • A01K67/0333Genetically modified invertebrates, e.g. transgenic, polyploid
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • G01N33/5085Supracellular entities, e.g. tissue, organisms of invertebrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43526Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms
    • G01N2333/4353Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes
    • G01N2333/43534Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/918Carboxylic ester hydrolases (3.1.1)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/924Hydrolases (3) acting on glycosyl compounds (3.2)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Environmental Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GB0109263A 1999-04-15 2000-04-14 Method of generating mutant C. elegans exhibiting increased compound uptake Expired - Fee Related GB2358400B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0109263A GB2358400B (en) 1999-04-15 2000-04-14 Method of generating mutant C. elegans exhibiting increased compound uptake

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9908677.9A GB9908677D0 (en) 1999-04-15 1999-04-15 Compound assay
GB0109263A GB2358400B (en) 1999-04-15 2000-04-14 Method of generating mutant C. elegans exhibiting increased compound uptake
GB0009360A GB2351152B (en) 1999-04-15 2000-04-14 Screen for pharmacological activity using nematode worms

Publications (3)

Publication Number Publication Date
GB0109263D0 true GB0109263D0 (en) 2001-05-30
GB2358400A GB2358400A (en) 2001-07-25
GB2358400B GB2358400B (en) 2002-01-16

Family

ID=26244117

Family Applications (2)

Application Number Title Priority Date Filing Date
GB0109263A Expired - Fee Related GB2358400B (en) 1999-04-15 2000-04-14 Method of generating mutant C. elegans exhibiting increased compound uptake
GB0109262A Expired - Fee Related GB2358399B (en) 1999-04-15 2000-04-14 Method of identifying mutant or transgenic nematodes exhibiting increased compound uptake

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0109262A Expired - Fee Related GB2358399B (en) 1999-04-15 2000-04-14 Method of identifying mutant or transgenic nematodes exhibiting increased compound uptake

Country Status (1)

Country Link
GB (2) GB2358400B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9906018D0 (en) * 1999-03-16 1999-05-12 Devgen Nv Expression of DNA or proteins in C.elegans

Also Published As

Publication number Publication date
GB2358400B (en) 2002-01-16
GB2358400A (en) 2001-07-25
GB0109262D0 (en) 2001-05-30
GB2358399A (en) 2001-07-25
GB2358399B (en) 2002-01-16

Similar Documents

Publication Publication Date Title
EP1382135A4 (en) Interference suppression methods for 802.11
AU2002215125A1 (en) Well treatment method
HK1035505A1 (en) Method of confirming performer of exercise.
ZA200108446B (en) Novel method of treatment.
GB2350852B (en) Well operating method
AU4787301A (en) 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds
HK1052702A1 (en) Method for the preparation of 5-carboxyphthalide.
HK1038166A1 (en) Toothbrush.
MXPA01013412A (en) Potassium calcium citrate compositions and methods for production.
HK1054848A1 (en) Toothbrush.
ZA992899B (en) Novel compound.
ZA200210361B (en) Method of administering bishosphonates.
ZA200007084B (en) Novel salts of N-tert-butylhydroxylamine.
HUP0004764A3 (en) Method for producing 4-methoxymethyl-2,3,5,6-tetrafluorobenzenealcohol
GB0109263D0 (en) Method of generating mutant C.elgans exhibiting increased compound uptake
HK1051179A1 (en) Prostaglandin e analogues.
HK1040248A1 (en) Process for the preparation of isoindoline.
IL146573A0 (en) Method for producing 2,2,4,4-tetra-substituted 1,3,5-cyclohexanetriones
EP1086261A4 (en) An anticorrosion treatment
ZA200007396B (en) Method of treatment.
AP2005003432A0 (en) Novel method of treatment.
PL347407A1 (en) Method of obtaining derivatives of 5,6,7,8-tetrahydronaphtalen-2-ole
HUP0200455A3 (en) Method for producing 4-amino-5-chloro-1-phenyl pyridazinone-(6)
PL331787A3 (en) Method of obtaining 2,3-dibromo-2-butene-1,4-diole
PL342955A1 (en) Method of obtaining 1,4:3,6-dianhydro-d,l-iditole from galactitole

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20090414